COMMUNIQUÉS West-GlobeNewswire

Senior Vice President and Chief Clinical Officer Dr. Hoda Asmar Advances Adventist Health Mission With New Patient-Centered Initiatives

01/05/2018 - 14:00

Western U.S. Nonprofit Integrated Health System Moves to Redesign the Delivery of Care and Increase Patient Safety and Engagement ROSEVILLE, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, [...]

VBL Therapeutics to Report First Quarter 2018 Financial Results on May 17

01/05/2018 - 14:00

TEL AVIV, Israel, May 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Selecta Biosciences to Present at Upcoming Investor Conferences

01/05/2018 - 14:00

WATERTOWN, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

VBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate Update

01/05/2018 - 14:00

-- Enrollment completed in PROTECT Phase 3 clinical study of Sci-B-Vac ® Hepatitis B Vaccine -- -- Key upcoming milestones in 2018 for lead eVLP vaccine candidates, VBI-1501 for prevention of Congenital Cytomegalovirus [...]

Jounce Therapeutics to Present at Deutsche Bank 43rd Annual Health Care Conference

01/05/2018 - 14:00

CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

CymaBay to Report First Quarter 2018 Financial Results on Tuesday, May 8

01/05/2018 - 14:00

NEWARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Atara Biotherapeutics Expands Commercial Leadership Team with the Appointment of Manuela Maronati as General Manager, Europe

01/05/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

Delcath Announces Ratio for Reverse Split Authorization

01/05/2018 - 14:00

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of [...]

Release date of three-month interim report (Q1) 2018 and audio cast

01/05/2018 - 13:40

On Friday, 4 May 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its interim report for the three months ended 31 March 2018. ALK will host a meeting for analysts and institutional investors that day at 1.30 [...]

Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients

01/05/2018 - 13:35

Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the [...]

Spark Therapeutics to Host Conference Call on Tuesday, May 8 at 8:30 a.m. ET to Discuss First Quarter Results and Recent Business Highlights

01/05/2018 - 13:30

PHILADELPHIA, May 01, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on [...]

Kura Oncology to Report First Quarter 2018 Financial Results

01/05/2018 - 13:30

SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

Epizyme Announces First Quarter 2018 Financial Reporting Date and Upcoming Conference Call

01/05/2018 - 13:30

First Quarter 2018 Financial Results to be Announced May 8, 2018 Investor Conference Call to be Scheduled for May 17, 2018 to Discuss Updated Interim Data from Tazemetostat Trials CAMBRIDGE, Mass., May 01, 2018 (GLOBE [...]

FDA Releases Theratechnologies from Post-Approval Commitments Related to EGRIFTA® (Tesamorelin for Injection)

01/05/2018 - 13:30

MONTREAL, May 01, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) today announced that the Food and Drug Administration (FDA) has released Theratechnologies from post-approval commitments [...]

La FDA dégage Theratechnologies de ses obligations post-approbation en lien avec EGRIFTA(MD) (tésamoréline pour injection)

01/05/2018 - 13:30

MONTRÉAL, 01 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) a annoncé aujourd’hui que la Food and Drug Administration (FDA) dégage Theratechnologies de ses obligations post- [...]

KemPharm, Inc. to Report First Quarter 2018 Results

01/05/2018 - 13:30

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for May 10, 2018, 4:30 p.m. ET CORALVILLE, Iowa, May 01, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a specialty pharmaceutical [...]

Scythian Biosciences Announces Extension of Letter of Intent

01/05/2018 - 14:45

TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement [...]

NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith

01/05/2018 - 14:39

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV ), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]

Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results and Corporate Update

01/05/2018 - 14:30

NOVATO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]